84
Views
0
CrossRef citations to date
0
Altmetric
Original Research

The Severity of Changes in Cardiovascular Risk Factors in Adults Over a Five-Year Interval

ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1979-1990 | Published online: 19 Oct 2020

References

  • Jayedi A, Rashidy-pour A, Khorshidi M, et al. Body mass index, abdominal adiposity, weight gain and risk of developing hypertension: a systematic review and dose-response metaanalysis of more than 2.3 million participants. Obes Rev. 2018;19:654–667. doi:10.1111/obr.1265629334692
  • European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice. Eur Heart J. 2012;98:941–946. doi:10.1093/eurheartj/ehs092
  • Conroy RM, Pyorala K, Fitzgerald A, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: SCORE project. Eur Heart J. 2003;24:987–1003. doi:10.1016/S0195-668X(03)00114-312788299
  • Vikhireva O, Pająk A, Broda G, et al. SCORE performance in central and Eastern Europe and former Soviet Union: MONICA and HAPPIE results. Eur Heart J. 2014;35:571–577. doi:10.1093/eurheartj/eht18923786858
  • DeFilippis AP, Yung R, Carrubba CJ, et al. An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. Ann Intern Med. 2015;126:266–275. doi:10.7326/M14-1281
  • Polskie Towarzystwo Nadciśnienia Tętniczego. Zasady postępowania w nadciśnieniu tętniczym — 2019 rok. Wytyczne Polskiego Towarzystwa Nadciśnienia Tętniczego. Nadcisnienie Tetnicze w Praktyce. 2019;5(1):1–86.
  • Pająk A, Szafraniec K, Janion M, et al. The impact of the Polish national programme of cardiovascular disease prevention on the quality of primary cardiovascular disease prevention in clinical practice. Kardiol Pol. 2010;68(12):1332–1341.21174285
  • Stanisz A. Przystępny Kurs Statystyki w Oparciu o Program STATISTICA PL Na Przykładach z Medycyny. StatSoft Polska; 1998.
  • Pólya G. Über den zentralen Grenzwertsatz der Wahrscheinlichkeitsrechnung und das Momentenproblem. Math Z. 1920;8(3):171–181. doi:10.1007/BF1206525
  • Fritz CO, Morris PE, Richler JJ. Effect size estimates: current use, calculations, and interpretation. J Ex Psychol Gen. 2012;141(1):2–18. doi:10.1037/a0024338
  • Cohen J. Statistical Power Analysis for the Behavioral Sciences 2nd Edition. Hillsdale, NJ: Erlbaum; 1998.
  • Grimm LG, Yarnold PR, editors. Reading and Understanding Multivariate Statistics. Washington, DC, US: American Psychological Association; 1995.
  • Hall DB, Woolson RF, Clarke WR, et al. Cochran-mantel-Haenszel techniques: applications involving epidemiologic survey data. Handbook Stat. 1997;18:483–500. doi:10.1016/S0169-7161(00)18018-6
  • Stol DM, Badenbroek IF, Hollander M, et al. Effectiveness of a stepwise cardiometabolic disease prevention program: results of a randomized controlled trial in primary care. Prev Med. 2020;132:105984. doi:10.1016/j.ypmed.2020.10598431954837
  • Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–223. doi:10.1016/S0140-6736(05)17741-115652604
  • Zdrojewski T, Solnica B, Cybulska B, et al. Prevalence of lipid abnormalities in Poland. The NATPOL 2011 survey. Kardiol Pol. 2016;74(3):213–223. doi:10.5603/KP.2016.002927004543
  • Kopeć G, Jankowski P, Pająk A, et al., editors. Epidemiologia i Prewencja Chorób Układu Krążenia. Kraków, Poland: Medycyna praktyczna; 2015.
  • Mongraw-Chaffin ML, Peters SAE, Huxley RR, et al. The sex-specific association between BMI and coronary heart disease: a systematic review and meta-analysis of 95 cohorts with 1·2 million participants. Lancet Diabetes Endocrinol. 2015;3(6):437–449. doi:10.1016/S2213-8587(15)00086-825960160
  • Liput-Sikora A, Cybulska AM, Fabian W, et al. Cardiovascular risk distribution in a contemporary Polish collective. Int J Environ Res Public Health. 2020;17(9):3306. doi:10.3390/ijerph17093306
  • Spalansky GL, Corey D, Yang Q, et al. The third generation cohort of the National Heart, Lung and Blood Institute’s Framingham Heart Study: design, recruitment and initial examination. Am J Epidemiol. 2007;165(11):1328–1335. doi:10.1093/aje/kwm02117372189
  • O’Donnell C, Elosua R. Cardiovascular risk factors. Insights from Framingham Heart Study. Rev Esp Cardiol. 2008;61(3):299–310. doi:10.1016/s1885-5857(08)60118-818361904
  • Mahmood SS, Levy D, Vasan RS, et al. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 2014;383(9921):999–1008. doi:10.1016/S0140-6736(13)61752-324084292
  • Tsao CW, Vasan RS. Cohort profile: the Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology. Int J Epidemiol. 2015;44(6):1800–1813. doi:10.1093/ije/dyv33726705418
  • Jayedi A, Rashidy-pour A, Soltani S, et al. Adult weight gain and the risk of cardiovascular disease: a systematic review and dose–response meta-analysis of prospective cohort studies. Eur J Clin Nutr. 2020;74(9):1263–1275. doi:10.1038/s41430-020-0610-y32203236
  • Aune D, Sen A, Norat T, et al. Body mass index, abdominal fatness, and heart failure incidence and mortality: a systematic review and dose-response meta-analysis of prospective studies. Circulation. 2016;133(7):639–649. doi:10.1161/CIRCULATIONAHA.115.01680126746176
  • Andolfi C, Fisichella PM. Epidemiology of obesity and associated comorbidities. J Laparoendosc Adv Surg Tech A. 2018;28(8):919–924. doi:10.1089/lap.2018.038030010474
  • Centers for Disease Control and Prevention (CDC). Smoking-attributable mortality, years of potential life lost, and productivity losses -United States, 2000–2004. MMWR Morb Mortal Wkly Rep. 2008;57(45):1226–1228.19008791
  • Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults and trends in smoking cessation – United States, 2008. MMWR Morb Mortal Wkly Rep. 2009;58(44):1227–1232.19910909
  • Mozos I, Maidana JP, Stoian D, Stehlik M. Gender differences of arterial stiffness and arterial age in smokers. Int J Environ Res Public Health. 2017;14(6):565. doi:10.3390/ijerph14060565
  • Reitsma MB, Fullman N, Ng M, GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017;389(10082):1885–1906. doi:10.1016/S0140-6736(17)30819-X28390697
  • Tomasik R, Dębska M, Gołas A, et al. Krajowe Rekomendacje Prozdrowotnej Aktywności Fizycznej - Raport Badawczo-Analityczny. Katowice, Poland: Ministerstwo Sportu i Turystyki. Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach; 2018.
  • Murphy MH, Donnelly P, Shibli S, et al. Physical activity, walking and leanness: an analysis of the Northern Ireland Sport and Physical Activity Survey (SAPAS). Prev Med. 2012;54(2):140–144. doi:10.1016/j.ypmed.2011.12.00822197800
  • Shannon HM, Little A, Murphy EA. Studies of male survivors of myocardial infarction due to “essential” atherosclerosis. Can Med Assoc Med. 1961;84(10):519–530.
  • Chow CK, Islam S, Bautista L, et al. Parental history and myocardial infarction risk across the world. The INTERHEART Study. JACC. 2011;5(57):619–627. doi:10.1016/j.jacc.2010.07.054